Lincoln Pharmaceuticals (BOM:531633) Total Assets : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Lincoln Pharmaceuticals Total Assets?

Lincoln Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil.

During the past 12 months, Lincoln Pharmaceuticals's average Total Assets Growth Rate was 2.00% per year. During the past 3 years, the average Total Assets Growth Rate was 10.40% per year. During the past 5 years, the average Total Assets Growth Rate was 7.20% per year. During the past 10 years, the average Total Assets Growth Rate was 7.10% per year.

During the past 13 years, Lincoln Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 41.90%. The lowest was 3.60%. And the median was 8.45%.

Total Assets is connected with ROA %. Lincoln Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 was 16.91%. Total Assets is also linked to Revenue through Asset Turnover. Lincoln Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 was 0.22.

Lincoln Pharmaceuticals Total Assets Historical Data

The historical data trend for Lincoln Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lincoln Pharmaceuticals Total Assets Chart

Lincoln Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

3,893.88

4,523.59

5,343.57

5,874.20

Lincoln Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															-	5,874.20	-	6,632.69	-

Lincoln Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Lincoln Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	5024.746	+	849.457
	=	5,874

Lincoln Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	N/A	+	N/A
	=	N/A

Lincoln Pharmaceuticals (BOM:531633) Total Assets Explanation

Total Assets is connected with ROA %.

Lincoln Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	1121.612	/	( (6632.686	+	0)	/ 1 )
	=	1121.612	/	6632.686
	=	16.91 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Lincoln Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	1464.493	/	( (6632.686	+	0)	/ 1 )
=	1464.493	/	6632.686
=	0.22

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Lincoln Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lincoln Pharmaceuticals (BOM:531633) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lincoln Pharmaceuticals Ltd (BOM:531633) » Definitions » Total Assets

Traded in Other Exchanges

LINCOLN:India

Address

Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060

Website

https://www.lincolnpharma.com

Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of Cardiac, Diabetic, Anti-malarial, Anti-biotic, Anti-fungal, Cephalosporin, Analgesic, Anaesthetics, Anti-pyretic, GIT products, Vitamin-Minerals, and Iron preparations. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.

Lincoln Pharmaceuticals (BOM:531633) Headlines

No Headlines